HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities.

AbstractOBJECTIVE:
To measure the changes in whole blood fatty acid levels in premature infants and evaluate associations between these changes and neonatal morbidities.
STUDY DESIGN:
This was a retrospective cohort study of 88 infants born at <30 weeks' gestation. Serial fatty acid profiles during the first postnatal month and infant outcomes, including chronic lung disease (CLD), retinopathy of prematurity, and late-onset sepsis, were analyzed. Regression modeling was applied to determine the association between fatty acid levels and neonatal morbidities.
RESULTS:
Docosahexaenoic acid (DHA) and arachidonic acid levels declined rapidly in the first postnatal week, with a concomitant increase in linoleic acid levels. Decreased DHA level was associated with an increased risk of CLD (OR, 2.5; 95% CI, 1.3-5.0). Decreased arachidonic acid level was associated with an increased risk of late-onset sepsis (hazard ratio, 1.4; 95% CI, 1.1-1.7). The balance of fatty acids was also a predictor of CLD and late-onset sepsis. An increased linoleic acid:DHA ratio was associated with an increased risk of CLD (OR, 8.6; 95% CI, 1.4-53.1) and late-onset sepsis (hazard ratio, 4.6; 95% CI, 1.5-14.1).
CONCLUSION:
Altered postnatal fatty acid levels in premature infants are associated with an increased risk of CLD and late-onset sepsis.
AuthorsCamilia R Martin, Deborah A Dasilva, Joanne E Cluette-Brown, Clementina Dimonda, Ashley Hamill, Abdul Q Bhutta, Emmanuel Coronel, Michael Wilschanski, Alisa J Stephens, David F Driscoll, Bruce R Bistrian, James H Ware, Munir M Zaman, Steven D Freedman
JournalThe Journal of pediatrics (J Pediatr) Vol. 159 Issue 5 Pg. 743-749.e1-2 (Nov 2011) ISSN: 1097-6833 [Electronic] United States
PMID21658712 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Mosby, Inc. All rights reserved.
Chemical References
  • Fatty Acids
  • Docosahexaenoic Acids
  • Arachidonic Acid
Topics
  • Arachidonic Acid (blood)
  • Chronic Disease
  • Cohort Studies
  • Docosahexaenoic Acids (blood)
  • Fatty Acids (blood)
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature (blood)
  • Lung Diseases (blood, epidemiology)
  • Male
  • Oxygen Inhalation Therapy
  • Proportional Hazards Models
  • Retinopathy of Prematurity (blood, epidemiology)
  • Retrospective Studies
  • Sepsis (blood, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: